Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stoltze

Showing results (191-200 of 211) with videos related to

Pageof 22
Sort By:
Cancer Genetics|May 9, 2026
Novel truncating WT1 germline variant in a case of familial Wilms tumorMira Marie Laustsen, Ulrik Kristoffer Stoltze, Karen Bonde Larsen, et al.
Journal of Medical Genetics|April 5, 2023
Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohortUlrik Kristoffer Stoltze, Mathis Hildonen, Thomas Van Overeem Hansen, et al.
NAR Genomics and Bioinformatics|February 18, 2026
DoBSeqWF: a framework for sensitive detection of individual genetic variation in pooled sequencing dataMads Cort Nielsen, Christian Munch Hagen, Ulrik Kristoffer Stoltze, et al.
Protein Science : a Publication of the Protein Society|December 3, 2022
RosettaDDGPrediction for high-throughput mutational scans: From stability to bindingValentina Sora, Adrian Otamendi Laspiur, Kristine Degn, et al.
Genome Medicine|March 15, 2023
Combinatorial batching of DNA for ultralow-cost detection of pathogenic variantsUlrik Kristoffer Stoltze, Christian Munch Hagen, Thomas van Overeem Hansen, et al.
Journal of Medical Genetics|September 24, 2024
Novel germline <i>TP53</i> variant (p.(Phe109Ile)) confers high risk of cancerAnna Byrjalsen, Ulrik Kristoffer Stoltze, Charlotte Lautrup, et al.
EMBO Reports|August 15, 2006
Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathologyRebecca Radde, Tristan Bolmont, Stephan A Kaeser, et al.
Cold Spring Harbor Molecular Case Studies|April 15, 2022
9p21.3 Microdeletion involving <i>CDKN2A/2B</i> in a young patient with multiple primary cancers and review of the literatureMarlene Richter Jensen, Ulrik Stoltze, Thomas Van Overeem Hansen, et al.
Neuro-Oncology|July 28, 2022
Genetic predisposition and evolutionary traces of pediatric cancer risk: a prospective 5-year population-based genome sequencing study of children with CNS tumorsUlrik Kristoffer Stoltze, Jon Foss-Skiftesvik, Thomas van Overeem Hansen, et al.
Leukemia|March 25, 2025
Overt and covert genetic causes of pediatric acute lymphoblastic leukemiaUlrik Stoltze, Stefanie V Junk, Anna Byrjalsen, et al.
Pageof 22

Showing results (191-200 of 211) with videos related to

Sort By:
Pageof 22
Cancer Genetics|May 9, 2026
Novel truncating WT1 germline variant in a case of familial Wilms tumorMira Marie Laustsen, Ulrik Kristoffer Stoltze, Karen Bonde Larsen, et al.
Journal of Medical Genetics|April 5, 2023
Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohortUlrik Kristoffer Stoltze, Mathis Hildonen, Thomas Van Overeem Hansen, et al.
NAR Genomics and Bioinformatics|February 18, 2026
DoBSeqWF: a framework for sensitive detection of individual genetic variation in pooled sequencing dataMads Cort Nielsen, Christian Munch Hagen, Ulrik Kristoffer Stoltze, et al.
Protein Science : a Publication of the Protein Society|December 3, 2022
RosettaDDGPrediction for high-throughput mutational scans: From stability to bindingValentina Sora, Adrian Otamendi Laspiur, Kristine Degn, et al.
Genome Medicine|March 15, 2023
Combinatorial batching of DNA for ultralow-cost detection of pathogenic variantsUlrik Kristoffer Stoltze, Christian Munch Hagen, Thomas van Overeem Hansen, et al.
Journal of Medical Genetics|September 24, 2024
Novel germline <i>TP53</i> variant (p.(Phe109Ile)) confers high risk of cancerAnna Byrjalsen, Ulrik Kristoffer Stoltze, Charlotte Lautrup, et al.
EMBO Reports|August 15, 2006
Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathologyRebecca Radde, Tristan Bolmont, Stephan A Kaeser, et al.
Cold Spring Harbor Molecular Case Studies|April 15, 2022
9p21.3 Microdeletion involving <i>CDKN2A/2B</i> in a young patient with multiple primary cancers and review of the literatureMarlene Richter Jensen, Ulrik Stoltze, Thomas Van Overeem Hansen, et al.
Neuro-Oncology|July 28, 2022
Genetic predisposition and evolutionary traces of pediatric cancer risk: a prospective 5-year population-based genome sequencing study of children with CNS tumorsUlrik Kristoffer Stoltze, Jon Foss-Skiftesvik, Thomas van Overeem Hansen, et al.
Leukemia|March 25, 2025
Overt and covert genetic causes of pediatric acute lymphoblastic leukemiaUlrik Stoltze, Stefanie V Junk, Anna Byrjalsen, et al.
Pageof 22